Proactive Investors - Run By Investors For Investors

LeanLife Health production equipment due soon as it sets up first facility in North America

The company has also acquired lab and testing equipment, it told investors
testubes
LeanLife has developed a patented process to isolate omega 3 fatty acids

Food additives group LeanLife Health Inc (CVE:LLP) says equipment needed to produce its omega 3 products will be delivered soon, sending shares slightly higher.

The main item is a BioCube processing plant, which, with associated apparatus, is estimated to cost $800,000. So far LeanLife has spent $630,000.

READ - LeanLife Health signs sales agreement with RD Heritage

The company has also acquired lab and testing equipment for essential testing of raw materials and finished product, it said.

Additional equipment is being ordered and will be set up in a new lab.

The firm has leased around 4,000 sq ft of industrial space in South Vancouver, where it will spend an estimated $350,000 on improvements, security systems and initial supplies.

The production capacity of the equipment is estimated as at least 2.5mln litres of product a year, the firm added.

It's a busy period for the firm.

Last week it struck a sales agreement with RD Heritage Group LLC for its omega 3 products.

RD Heritage will market and sell the company's products and assist with marketing strategies.

It will also carry out market analysis to define a global sales strategy and appoint distributors to increase sales opportunities.

LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds.

The products are sold as a food additive to food processors making such items as bread, noodles and milk products.

In Toronto, LeanLife shares gained 3.03% to C$0.34.

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

A man's knee pain is highlighted with a red area that points to inflammation
January 23 2019
The injectable PPS trial has had a clinically meaningful and statistically significant result in patients with arthritic knee pain.
test tubes
May 02 2019
Proactive takes a closer look at an innovative drugs company that has largely flown under the radar
consumer health segment overview
January 11 2019
The company sells clinically validated anti-ageing products for hair, skin and body.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use